Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:REGN
Tag: NASDAQ:REGN
Analyst Downgrades – Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Gets Downgraded By Canaccord...
ME Staff
-
February 21, 2018
0
Analyst Activity – BTIG Research Reiterates Hold on Regeneron Pharmaceuticals (NASDAQ:REGN)
ME Staff
-
February 13, 2018
0
Regeneron Pharmaceuticals (NASDAQ:REGN) reported earnings of $5.23 per share beating Walls...
ME Staff
-
February 8, 2018
0
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) And Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Just Put...
-
November 28, 2017
0
REGENERON PHARMACEUTICALS, INC. (NASDAQ:REGN) Files An 8-K Results of Operations and...
ME Staff 8-k
-
November 8, 2017
0
Sanofi SA (ADR)(NYSE:SNY), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Dupixent Meets The Primary...
Andy Parker
-
October 18, 2017
0
REGENERON PHARMACEUTICALS,INC. (NASDAQ:REGN) Files An 8-K Submission of Matters to a...
ME Staff 8-k
-
September 13, 2017
0
Sanofi SA (ADR) (NYSE:SNY), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Announce Breakthrough Designation...
-
September 11, 2017
0
REGENERON PHARMACEUTICALS, INC. (NASDAQ:REGN) Files An 8-K Results of Operations and...
ME Staff 8-k
-
August 3, 2017
0
Analyst Activity – Piper Jaffray Companies Reiterates Overweight on Regeneron Pharmaceuticals...
ME Staff
-
August 1, 2017
0
1
2
3
...
5
Page 2 of 5
